As both a clinician-scientist and practicing geriatrician, one of my goals is to foster new collaborations between experts who come from different disciplines ranging from the basic laboratory to the clinic. In doing so, my vision is to broaden the scope and ability of medicine to answer relevant clinical questions and to improve the lives of persons as they age into their senior years. My main clinical and research expertise has been in geriatrics, hyperkyphosis, osteoporosis, and clinical epidemiology. I serve or have served as either principal investigator or co-investigator on several multi-institutional collaborative studies, including the Study of Osteoporotic Fractures, the Rancho Bernardo Study, the Osteoporotic Fractures in Men Study (MrOS) and the Framingham Offspring Study. More recently, I have delved into the effects of cancer treatments on the rate of aging, and thanks to C3 pilot funding from 2015, my work has expanded to better understand how cytotoxic chemotherapy impacts rates of aging in women with newly diagnosed breast cancer.